[1]
Acheson J Duncan.Quality Control and Industrial Statistics. . (1986)
Google Scholar
[2]
Bauer P,Bauer MM.Testing equivalence simultaneously for location and dispersion of two normally distributed population. Biometrical Journal . (1994)
DOI: 10.1002/bimj.4710360602
Google Scholar
[3]
Hung HMJ,Wang SJ,Robert O'Neill.A regulatory perspective on choice of margin and inference issue in non-inferiority trials. Biomet-rical Journal . (2005)
Google Scholar
[4]
Pan Zhenyu, Zhao Naiqing. The test of general distribution and multivariate normal distribution [J]. Journal of Mathematical Medicine, 2006,01:53-55.
Google Scholar
[5]
Zheng Zhaobao. The generation and test for the random data of normal distribution [J]. Wuhan Institute of Surveying and mapping, 1980,01:85-92.
Google Scholar
[6]
Li Xiuhai, Yu Shaowei. The droplet acquisition algorithm based on the number of normal distribution interval [J]. Journal of Shandong University ( Engineering and Technology Edition ), 2012,05:130-134.
Google Scholar
[7]
Chan IS.Proving non-inferiority or equivalence of two treatment with dichotomous endpoints using exact methods. Statistical Methods in Medical Research . (2003)
DOI: 10.1191/0962280203sm314ra
Google Scholar
[8]
Wang IK.Active-controlled noninferiority/equivalence trials:method and practice. Statistics in the pharmaceutical industry . (2006)
Google Scholar
[9]
George A,Diamond MD,Sanjay Kaul MD.An orwellian discourse on the meaning and measurement of noninferiority. The American Journal of Cardiology . (2007)
Google Scholar
[10]
Kim MY,Xue XN.Likelihood ratio and a Bayesian approach were su-perior to standard noninferiority analysis when the noninferiority margin varied with the control event rate. Journal of Clinical Epidemiology . (2004)
DOI: 10.1016/j.jclinepi.2004.05.005
Google Scholar
[11]
Grieve AP.Joint equivalence of means and variances of two popula-tions. Journal of Biopharmaceutical Statistics . (1998)
Google Scholar
[12]
Wiens,B.Choosing an equivalence limit for noninferiority or equivalence studies. Controlled Clinical Trials . (2002)
DOI: 10.1016/s0197-2456(01)00196-9
Google Scholar
[13]
Committee for Proprietary Medicinal Products (CPMP).Points to consider on switching between superiority and non-inferiority. British Journal of Clinical Pharmacology . (2001)
DOI: 10.1046/j.1365-2125.2001.01397-3.x
Google Scholar